New research found that mRNA vaccines for COVID-19 could enhance cancer treatments and help patients live longer.

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

A new mRNA platform targets tumors with precision, limits side effects, and converts immune-silent cancers into responsive ones for stronger treatment outcomes.

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

RNA-based therapeutics are transforming medicine, but scaling production efficiently remains a challenge, particularly the ...

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and significantly improve chronic disease outcomes for at-risk patients, today announced a ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...